SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...
Large European cohort data suggest hydroxyurea pregnancy exposure in sickle cell disease is not linked to congenital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results